We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
-14.8%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$13.1B
AUM Growth
-$2.86B
Cap. Flow
-$262M
Cap. Flow %
-2%
Top 10 Hldgs %
37.9%
Holding
1,479
New
56
Increased
646
Reduced
399
Closed
58

Top Buys

Rank Stock Value
1
MAA icon
Mid-America Apartment Communities
MAA
+$174M
2
EQIX icon
Equinix
EQIX
+$83.3M
3
DLR icon
Digital Realty Trust
DLR
+$82.9M
4
PLD icon
Prologis
PLD
+$52.3M
5
INVH icon
Invitation Homes
INVH
+$39.6M

Top Sells

Rank Stock Value
1
AMT icon
American Tower
AMT
+$263M
2
VICI icon
VICI Properties
VICI
+$230M
3
ESS icon
Essex Property Trust
ESS
+$96.1M
4
VTR icon
Ventas
VTR
+$61.2M
5
EBIZ icon
Global X E-commerce ETF
EBIZ
+$39.2M

Sector Composition

Rank Sector Weight
1 Real Estate 60.75%
2 Technology 8.8%
3 Healthcare 4.18%
4 Consumer Discretionary 3.61%
5 Financials 3.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PLRX icon
1276
Pliant Therapeutics
PLRX
$66.9M
$1K ﹤0.01%
123
– –
PRLD icon
1277
Prelude Therapeutics
PRLD
$310M
$1K ﹤0.01%
104
– –
PSNL icon
1278
Personalis
PSNL
$1.28B
$1K ﹤0.01%
152
– –
PTGX icon
1279
Protagonist Therapeutics
PTGX
$8.72B
$1K ﹤0.01%
163
– –
QSI icon
1280
Quantum-Si Incorporated
QSI
$171M
$1K ﹤0.01%
343
– –
RANI icon
1281
Rani Therapeutics
RANI
$91M
$1K ﹤0.01%
58
– –
RLYB icon
1282
Rallybio
RLYB
$86.6M
$1K ﹤0.01%
12
– –
RYTM icon
1283
Rhythm Pharmaceuticals
RYTM
$7.28B
$1K ﹤0.01%
172
– –
SEER icon
1284
Seer Inc
SEER
$108M
$1K ﹤0.01%
166
– –
SRRK icon
1285
Scholar Rock
SRRK
$5.86B
$1K ﹤0.01%
118
– –
STRO icon
1286
Sutro Biopharma
STRO
$398M
$1K ﹤0.01%
16
– –
TKNO icon
1287
Alpha Teknova
TKNO
$260M
$1K ﹤0.01%
82
– –
TNYA icon
1288
Tenaya Therapeutics
TNYA
$167M
$1K ﹤0.01%
120
– –
TRML
1289
DELISTED
Tourmaline Bio
TRML
$1K ﹤0.01%
12
– –
VOR icon
1290
Vor Biopharma
VOR
$1.05B
$1K ﹤0.01%
5
– –
XERS icon
1291
Xeris Biopharma Holdings
XERS
$1.42B
$1K ﹤0.01%
404
– –
KLRS
1292
Kalaris Therapeutics
KLRS
$85.2M
$1K ﹤0.01%
10
– –
CMRX
1293
DELISTED
Chimerix, Inc.
CMRX
$1K ﹤0.01%
253
– –
OMGA
1294
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$1K ﹤0.01%
139
– –
EGRX
1295
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$1K ﹤0.01%
30
– –
GTHX
1296
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$1K ﹤0.01%
145
– –
TWOU
1297
PUT
DELISTED
2U Inc
TWOU
$1K ﹤0.01%
33
– –
OMIC
1298
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$1K ﹤0.01%
7
– –
ALPN
1299
DELISTED
Alpine Immune Sciences Inc
ALPN
$1K ﹤0.01%
85
– –
GRCL
1300
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
$1K ﹤0.01%
146
– –
50 51
52
53 54

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q2 2022 Portfolio in Review

As of Q2 2022, Daiwa Securities Group held 1,479 positions worth $13.1B, down 18% from $16B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Daiwa Securities Group's Q2 2022 filing shows 56 new, 646 increased, 399 reduced and 58 closed positions. Its largest new stake was HDFC Bank: 143,030 shares worth $3.93M. The largest sale was American Tower, an estimated $263M.

By sector, the portfolio is most concentrated in Real Estate at 61% of assets, up from 60% a quarter earlier, followed by Technology and Healthcare.

  • Daiwa Securities Group's largest Q2 2022 buy was HDFC Bank: 143,030 shares worth $3.93M.
  • Daiwa Securities Group added most to Mid-America Apartment Communities in Q2 2022, an estimated $174M increase.
  • Daiwa Securities Group's biggest Q2 2022 reduction was American Tower, cutting an estimated $263M.
  • Daiwa Securities Group fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $7.68M.
  • Daiwa Securities Group's ten largest holdings make up 38% of its $13.1B portfolio in Q2 2022.
  • Daiwa Securities Group opened 56 new positions and closed 58 in Q2 2022.
  • Daiwa Securities Group's portfolio value fell 18% quarter-over-quarter to $13.1B.

Based on Daiwa Securities Group's 13F filing for Q2 2022, filed 9 Aug 2022.